Synbio Tech Inc. (TPEX:1295)
Taiwan · Delayed Price · Currency is TWD 46.50
-0.55 (-1.17%)
Aug 26, 2026, 1:30 PM CST
Synbio Tech Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 1,007 | 1,039 | 989.48 | 823.3 | 739.33 | |
Revenue Growth | -5.28% | 4.97% | 20.18% | 11.36% | - |
Cost of Revenue | 503.07 | 483.47 | 448.64 | 404.56 | 378 |
Gross Profit | 503.48 | 555.2 | 540.84 | 418.75 | 361.33 |
Selling, General & Admin | 248.24 | 237.95 | 222.88 | 275.79 | 259.49 |
Research & Development | 125.03 | 118.84 | 108.57 | - | - |
Operating Expenses | 373.27 | 356.94 | 331.45 | 275.79 | 259.82 |
Operating Income | 130.21 | 198.26 | 209.4 | 142.96 | 101.5 |
Interest Expense | -29.66 | -12.67 | -3.71 | -6.6 | -7.69 |
Interest & Investment Income | 9.29 | 9.54 | 9.27 | 7.34 | 6.54 |
Currency Exchange Gain (Loss) | -6.02 | -6.02 | 14.17 | -3.16 | 10.08 |
Other Non Operating Income (Expenses) | 48.12 | 14.08 | 7.47 | 6.58 | 5.27 |
EBT Excluding Unusual Items | 151.94 | 203.19 | 236.59 | 147.12 | 115.7 |
Gain (Loss) on Sale of Assets | -0.83 | -0.83 | - | -0.06 | - |
Pretax Income | 151.11 | 202.36 | 236.59 | 147.07 | 115.7 |
Income Tax Expense | 9.05 | 26.4 | 66.47 | 33.8 | 23.18 |
Net Income | 142.06 | 175.97 | 170.13 | 113.27 | 92.52 |
Net Income to Common | 142.06 | 175.97 | 170.13 | 113.27 | 92.52 |
Net Income Growth | -21.29% | 3.44% | 50.19% | 22.43% | - |
Shares Outstanding (Basic) | 34 | 33 | 31 | 31 | 31 |
Shares Outstanding (Diluted) | 35 | 33 | 32 | 31 | 31 |
Shares Change | 8.69% | 5.85% | 0.01% | 0.02% | - |
EPS (Basic) | 4.12 | 5.29 | 5.43 | 3.61 | 2.96 |
EPS (Diluted) | 4.11 | 5.28 | 5.40 | 3.60 | 2.94 |
EPS Growth | -27.59% | -2.22% | 50.08% | 22.33% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -290.89 | -559.72 | -40.62 | -113.36 | -29.54 |
Free Cash Flow Per Share | -8.41 | -16.79 | -1.29 | -3.60 | -0.94 |
Dividend Per Share | - | 3.000 | 3.500 | 1.471 | 1.961 |
Dividend Growth | - | -14.29% | 138.00% | -25.00% | - |
Gross Margin | 50.02% | 53.45% | 54.66% | 50.86% | 48.87% |
Operating Margin | 12.94% | 19.09% | 21.16% | 17.36% | 13.73% |
Profit Margin | 14.11% | 16.94% | 17.19% | 13.76% | 12.51% |
Free Cash Flow Margin | -28.90% | -53.89% | -4.11% | -13.77% | -4.00% |
EBITDA | 239.93 | 270.62 | 278.02 | 215.04 | 173.4 |
EBITDA Margin | 23.84% | 26.05% | 28.10% | 26.12% | 23.45% |
D&A For EBITDA | 109.72 | 72.36 | 68.63 | 72.08 | 71.9 |
EBIT | 130.21 | 198.26 | 209.4 | 142.96 | 101.5 |
EBIT Margin | 12.94% | 19.09% | 21.16% | 17.36% | 13.73% |
Effective Tax Rate | 5.99% | 13.04% | 28.09% | 22.98% | 20.03% |